CN105920059A - Chimonanthus praecox extract as well as preparation method and application thereof - Google Patents

Chimonanthus praecox extract as well as preparation method and application thereof Download PDF

Info

Publication number
CN105920059A
CN105920059A CN201610394829.3A CN201610394829A CN105920059A CN 105920059 A CN105920059 A CN 105920059A CN 201610394829 A CN201610394829 A CN 201610394829A CN 105920059 A CN105920059 A CN 105920059A
Authority
CN
China
Prior art keywords
sieb
prunus mume
wax prunus
extract
wax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610394829.3A
Other languages
Chinese (zh)
Inventor
朱剑虹
王智富
朱侗明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI SHENYIN BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
SHANGHAI SHENYIN BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI SHENYIN BIOLOGICAL TECHNOLOGY Co Ltd filed Critical SHANGHAI SHENYIN BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN201610394829.3A priority Critical patent/CN105920059A/en
Publication of CN105920059A publication Critical patent/CN105920059A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/17Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82Preparation or application process involves sonication or ultrasonication

Abstract

The invention discloses a chimonanthus praecox extract which is prepared from 5-20% of kaempferol, 10-30% of quercetin, 50-60% of scyllitol and inevitable impurities. The chimonanthus praecox extract is obtained by freeze-drying a chimonanthus praecox material by using liquid nitrogen, then grinding the chimonanthus praecox material into powder, adding an extracting agent into the powder, ultrasonically leaching an obtained mixture for 0.5-2h at 35-60 DEG C, carrying out centrifugation and filtration after terminating the leaching, collecting filtrate and carrying out chromatographic purification through a chromatographic column. The chimonanthus praecox extract provided by the invention can protect skin and reduce the disoperation by microorganisms, and has the functions of reducing ultraviolet radiation, resisting oxidation and resisting inflammations of the skin, so as to protect cells of the skin; the chimonanthus praecox extract is applied to cosmetics or health products, and can also reduce pigmentation, inhibit the generation of stains and enable the skin to be fair and bright.

Description

A kind of wax prunus mume extract, its preparation method and application
Technical field
The invention belongs to plant component and extract field, be specifically related to a kind of wax prunus mume extract, its preparation side Method and application.
Background technology
Wax prunus mume (sieb.) sieb.et zucc., has another name called chimonanthi,flos, fragrant prunus mume (sieb.) sieb.et zucc., originates in from China, grows thickly filling for Calycanthaceae wax-cakes bait fallen leaves Wood.Wax prunus mume (sieb.) sieb.et zucc. old origin, for Relict Plant in the Tertiary Period, one of Yi Shi China tradition famous flower.Wax prunus mume (sieb.) sieb.et zucc. makees For the traditional flowers of China, also it is one of significant flowers, is loved by the people from ancient times, in middle Chinese Why in change, the wax plum curculio of thirty years of age levies moral the cold winter, " cold to the bone without some, Flos Mume is assailed the nostrils perfume (or spice) " The most wide-spread Deng classical verse.
Flos Chimonanthi Praecocis was opened the cold early spring moon, first spent posterior lobe, and brightly yellowish as cured, delicate fragrance overflows, and views and admires for winter Good merchantable brand, is the distinctive precious ornamencal flower and tree of China.Wax definiteness happiness sunlight, the most resistance to half the moon, aversion to wind, relatively Cold-resistant, the energy safe overwintering when being not less than-15 DEG C, Beijing areas to the south can outdoor cropping.Wax prunus mume (sieb.) sieb.et zucc. is not only Being preferable ornamental flower, it is possible to do cut-flower, miniature gardening, flower can make tea, makes wine, is used as medicine, extract perfume Essence, its root, stem and leaf also has the effectiveness such as cough-relieving.
For a long time, sight is concentrated on wax prunus mume (sieb.) sieb.et zucc. as tea-drinking, essence, the purposes of Chinese medicine by people, right When wax prunus mume (sieb.) sieb.et zucc. is extracted, utilize ultrasound assisted extraction to take low frequency (10-20KHz) and intermediate frequency more (40kHz), when separating, eluant with the addition of alcohols solvent (such as butanediol-acetone system), Eluant system polarity is relatively big, and the component classification of extract is numerous and diverse and mostly is volatile material, extracts Thing composition instability, impact application effect, application is restricted.
And study and show, people are exposed in sunlight, atmosphere pollution for a long time, and body can produce too much Active oxygen and free radical, cause the Antioxidants of human body self to decline, cause cell viability Reducing, human body metabolic disorder, even infecting by harmful microorganism, finally makes skin accelerate Aging, the colour of skin is obscure, and acne is red and swollen, and application based on current wax prunus mume extract limits, by wax Prunus mume (sieb.) sieb.et zucc. is applied to the purposes of skin care after extracting, and there is not been reported.
Summary of the invention
It is an object of the invention to provide a kind of wax prunus mume extract, its preparation method and application, this extraction Thing can protect Skin Cell, has microorganism encroach, the ultraviolet radiation reducing skin and being suffered, Antioxidation etc. act on, it is also possible to play the effect of opposing scytitis, moreover it is possible to reduce pigmentation, press down Mottle processed generates, and it is vivid to make that skin and muscles are fair.
In order to achieve the above object, the technical scheme that the present invention provides is as follows:
A kind of wax prunus mume extract, its each weight percentages of components is: nimbecetin 5~20%, Quercetin 10~30%, Cocositol 50~60%, and inevitably impurity.
The preparation method of wax prunus mume extract of the present invention, comprises the following steps:
1) by wax prunus mume (sieb.) sieb.et zucc. material clean, shred, sterilize;
2) by the wax prunus mume (sieb.) sieb.et zucc. material liquid nitrogen lyophilizing after sterilization, pulverizing, extractant is added, at airtight condition Under, ultrasonic extraction 0.5~2h, extraction temperature is 35~60 DEG C, supersonic frequency 60-100kHz;Wherein, The mass volume ratio of wax prunus mume (sieb.) sieb.et zucc. and extractant is 1:30~60;
3) it is centrifuged after extraction terminates, filters, collect filtrate, obtain the solution of wax prunus mume extract;
4) by step 3) solution of wax prunus mume extract that obtains, concentrate, utilize chromatographic column to chromatograph Purification, gradient elution, eluant is petroleum ether-acetone;
5) collect eluent, dry, obtain described wax prunus mume (sieb.) sieb.et zucc. branch extract.
Further, step 2) in, step 2) described in extractant selected from 70~90% water of ethanol At least one in the aqueous solution of solution, ethyl acetate and saturated n-butyl alcohol.
Preferably, step 2) in, the mass ratio of wax prunus mume (sieb.) sieb.et zucc. material and extractant is 1:35~45.
The most preferably, described step 2) carry out under anaerobic.
Further, step 4) in, when utilizing column chromatography purification, with silica column purification 2~5 times, Purify 2~5 times with hydroxypropyl dextran gel column chromatography, collect petroleum ether and acetone volume in eluant Than the eluent when 100:6~12.
Further, described wax prunus mume (sieb.) sieb.et zucc. material is the branch of wax prunus mume (sieb.) sieb.et zucc. plant, stem, leaf or flower.
The present invention provides a kind of compositions comprising described wax prunus mume extract, including: glycerol 2~7wt.%, Butanediol 3~5wt.%, 1,2-pentanediol 1~5wt.%, EDETATE SODIUM 0.1~0.4wt.%, glycerol Stearate 1~3wt.%, hyaluronate sodium 0~0.1wt.%, xanthan gum 1~10wt.%, wax prunus mume (sieb.) sieb.et zucc. carry Taking thing 2~8wt.%, surplus is water.
The wax prunus mume extract of the present invention can be applicable in the preparation of cosmetics or health product, described cosmetic Product preferred whitening class, anti-acne and/or antibacterial class cosmetics.
When wax prunus mume (sieb.) sieb.et zucc. material is extracted by the present invention, supersonic frequency is 60-100kHz, and higher is ultrasonic Frequency can add the dissolution of fast component, and can improve the dissolubility of solute, carries out wax prunus mume extract During column chromatography purification, use petroleum ether-acetone eluant system, gradient elution, obtain petroleum ether and third The volume ratio of the ketone eluent when 100:6~12, the wax prunus mume extract obtained contains abundant Rhizoma Kaempferiae Phenol, Quercetin and Cocositol.
The wax prunus mume extract of the present invention contains abundant nimbecetin, Quercetin and Cocositol, it is possible to protection The effects such as skin reduces microorganism encroach, has minimizing ultraviolet radiation, antioxidation, thus protect skin Skin cell, wherein nimbecetin and Quercetin can also play opposing scytitis effect, meanwhile, Can also scavenging activated oxygen, suppress tyrosinase activity, and then inhibit mottle to generate, make skin white Fair-skinned vivid.
Containing nimbecetin in the wax prunus mume extract of the present invention, mass percent is 5%~20%, nimbecetin Having non-oxidizability, nimbecetin demonstrates the array with antioxidation in vitro and in vivo, During low concentration, superoxides scavenger can be served as, particularly to the hydroxyl radical free radical of high response and Peroxynitrite species, in high concentration, it increases antioxidase such as superoxide dismutase, mistake Hydrogen oxide enzyme, and the activity of Heme oxygenases-1 or expression, and the microorganisms such as antibacterial can be suppressed Growth, for skin provide multiple protective.
Containing Quercetin in the wax prunus mume extract of the present invention, mass percent is: 10%~30%, its Content in wax prunus mume (sieb.) sieb.et zucc. branch is the abundantest, and Quercetin has the resistance promoting capillary of skin, alleviates Sensitive skin, it helps the growth of Skin Cell and vigor keep.
Containing Cocositol in the wax prunus mume extract of the present invention, mass percent is 50%~60%, shark flesh Alcohol can disconnect ester bond, decomposes cholesterol and the granule of fat Cheng Geng little, reduces skin surface lipid heap Long-pending, reduce the generation of skin fat grain, make skin fine and smooth, promote skin vitality, improve skin physiology State.
Beneficial effects of the present invention:
The present invention, by extracting isolated wax prunus mume (sieb.) sieb.et zucc. branch extract, organically combines wax prunus mume (sieb.) sieb.et zucc. institute rich The three kinds of composition nimbecetins contained, Quercetin and Cocositol, these three composition cooperates, Quercetin with Nimbecetin has antibacterial effect, and the cleaning of ester matter can be destroyed the growth ring of pathogenic bacteria by Cocositol Border, strengthens bacteriostasis;Nimbecetin can protect vascular endothelial growth with scavenging activated oxygen Microenvironment, is more beneficial for the blood capillary of Quercetin protection skin, and therefore, three kinds of materials present collaborative Relation, it is possible to obtain more preferably effect.
Accompanying drawing explanation
Fig. 1 is the standard curve of hyaluronic acid in the embodiment of the present invention 2.
Fig. 2 is the increased percentage of hyaluronic acid in the embodiment of the present invention 2.
Fig. 3 is the survival rate change of skin flbroblast in the embodiment of the present invention 3.
Detailed description of the invention
Below in conjunction with the drawings and specific embodiments, the invention will be further described.
Embodiment 1
Utilize wax prunus mume (sieb.) sieb.et zucc. branch to prepare wax prunus mume extract, comprise the following steps:
1) 50g wax prunus mume (sieb.) sieb.et zucc. branch is cleaned, shreds, sterilizes;
2) by the wax prunus mume (sieb.) sieb.et zucc. branch liquid nitrogen lyophilizing after sterilization, pulverizing, 2L ethanol is added, at airtight bar Under part, temperature is 50 DEG C, ultrasonic extraction 1h, supersonic frequency 80kHz;
3) it is centrifuged after extraction terminates, filters, collect and obtain 500mL filtrate;
4) by step 3) filtrate concentrate after, utilize chromatographic column to be purified, cross 200~300 mesh silicon Glue chromatographic column 2~5 times, hydroxypropyl dextran gel column chromatography 2~5 times, eluant is petroleum ether-the third The volume ratio of ketone, gradient elution, petroleum ether and acetone (collects petroleum ether from 100:0 to 100:14 It is the product of 100:6,100:8,100:10 and 100:12 with acetone volume ratio).
5) collect eluent, concentrate, dry, obtain 0.8g extract.
In the present embodiment, by the adjustment number of times of chromatography concentrated filtrate, obtain different containing Amount combination, such as:
Wax prunus mume extract 1, excessively silica gel chromatographic column 3 times, hydroxypropyl dextran gel column chromatography 3 times: Nimbecetin (84mg/g), Quercetin (120mg/g), Cocositol (537mg/g);
Wax prunus mume extract 2, excessively silica gel chromatographic column 4 times, hydroxypropyl dextran gel column chromatography 4 times: Nimbecetin (61mg/g), Quercetin (280mg/g), Cocositol (508mg/g);
Wax prunus mume extract 3, excessively silica gel chromatographic column 2 times, hydroxypropyl dextran gel column chromatography 2 times: Nimbecetin (150mg/g), Quercetin (192mg/g), Cocositol (588mg/g).
Embodiment 2 uses wax prunus mume extract to verify the bacteriostasis of microbial infection
Hyaluronic acid is by fibroblasts to secrete, and the secretory volume of hyaluronic acid can embody skin Fibrocyte is to by bacteriostasis during microbial infection.
1. prepare the Skin Cell of people
Take the dermal fibroblast of normal person as primary cell, in 75cm2Culture bottle (contains Culture medium 2ml of somatomedin), 37 DEG C, CO2Concentration is to cultivate cell under conditions of 5% to 80% Concentration, passes on, passage cell continue in 175cm2 square vase cultivate cell to 80% concentration, Obtain fibroblasts of adult human dermis.
People obtained above is cultivated true with the DMEM culture fluid containing volume fraction 10% hyclone Skin fibroblast, in 37 DEG C, 5%CO2Cultivate 24 hours, treat that cell is close and merge, with containing 0.25% Pass on by 1:2 after the Digestive system digestion of trypsin and 0.02%EDTA, choose forth generation cell.
With the DMEM culture fluid containing 10% hyclone, forth generation cell being diluted to density is 105 Individual cell/ml, inoculates in 12 orifice plates, and inoculum concentration is 2 × 103Individual cells/well, cultivates to cell After merging close to 80%, wash plate 3 times with normal saline, obtain being vaccinated with fibroblasts of adult human dermis Orifice plate.
2. prepare to treat test agent
Preparation wax prunus mume extract essence, essence composition: glycerol 5.0wt.%, butanediol 4.0wt.%, 1,2-pentanediol 3.0wt.%, EDETATE SODIUM 0.1wt.%, glyceryl stearate 1.5wt.%, transparent Matter acid sodium 0.05wt.%, xanthan gum 4.0wt.%, wax prunus mume extract 3 5.0wt.% of embodiment 1, Surplus is deionized water.
Propionibacterium acnes is coated in LB culture medium, 37 DEG C of incubators are cultivated 48h, meter The bacterial population obtained, and be inoculated in above-mentioned steps 1 by each culture hole 500 bacterial population) in obtain 12 orifice plates being vaccinated with fibroblasts of adult human dermis in, choose 15 in two 12 orifice plates thin The hole of bacterium inoculation, wherein 5 Kong Weiyi groups, if 3 groups of parallel controls, in 5 holes often organized respectively Add A sample (essence 0.01mL+ normal saline 0.29mL), B sample (essence 0.05mL + normal saline 0.25mL), C sample (essence 0.1mL+ normal saline 0.2mL), D sample (essence 0.3mL) and control sample (0.3mL normal saline), at 37 DEG C, 5%CO2 Under the conditions of cultivate 12h, collect A sample, B sample, C sample, D sample and comparison the most respectively The culture supernatant of group sample is standby, containing being infected by propionibacterium acnes in this culture supernatant Fibroblasts of adult human dermis.
3. draw hyaluronic acid standard curve
Preparing 6 hyaluronic acid standard solutions, concentration is followed successively by: 0 μ g/mL, 10 μ g/mL, 20 μ g/mL, 40 μ g/mL, 80 μ g/mL, 160 μ g/mL, utilize microplate reader to test at 450 nm Its OD value, test result sees table 1.
Table 1
According to people's hyaluronic acid enzyme immunoassay test kit (Mei Lian bio tech ltd, Shanghai) Description, according to hyaluronic acid standard substance test result, with OD value as the longitudinal axis, dense with hyaluronic acid Spend the standard curve drawing hyaluronic acid for transverse axis, see Fig. 1;OD=0.0171 × c+0.2857, Coefficient R2=0.977, p=0.004, wherein, c is the concentration of hyaluronic acid, unit μ g/mL, Through converting, hyaluronic acid concentration c=(OD-0.2857)/0.0171.
4. carry out hyaluronic acid contents mensuration
According to people's hyaluronic acid enzyme immunoassay test kit description, employment hyaluronic acid enzyme linked immunological Solvent in assay kit is by the A sample got ready in step 2, B sample, C sample, D sample Dilute 5 times respectively with the culture supernatant of control sample, measure the A sample after dilution 5 times, B The OD value of the culture supernatant of sample, C sample, D sample and control sample, further according to transparent The standard curve of matter acid calculates hyaluronic acid contents, and result sees table 2 and Fig. 2.
Table 2
Matched group B sample C sample D sample
Dilute 5 times and record OD (450nm) 0.48 0.63 0.81 0.56
Hyaluronic acid concentration c (μ g/ml) 56.81 100.67 153.30 80.20
Content is (%) compared with matched group 0.0% 77.2% 169.9% 41.2%
By table 2 and Fig. 2 it can be seen that add the essence of the wax prunus mume (sieb.) sieb.et zucc. branch extract preparation of the present invention After, fibroblasts of adult human dermis content of secretion hyaluronic acid under the infecting of propionibacterium acnes has aobvious Writing and improve, hyaluronic acid is reflected by fibroblasts to secrete, the increase of hyaluronic acid secretion amount This wax prunus mume (sieb.) sieb.et zucc. branch extract contributes to skin flbroblast and supports antimicrobial infecting.
Embodiment 3 verifies the resistance to pathogenic microorganism of wax prunus mume extract
1. collect cell
Collect A sample, B sample, C sample, D sample and comparison in step 2 in embodiment 2 Fibroblasts of adult human dermis in the culture supernatant of group sample, in rotating speed 500~1000r/min condition Under be centrifuged 5min, take lower sediment, i.e. fibroblasts of adult human dermis, wash with 1mlPBS buffer Wash 1 time, then be centrifuged, discard PBS, the ethanol of the 70% of addition ice pre-cooling, be fixed, 4 DEG C, 1~2 hour, the centrifugal fixative that discards, resuspended 5 minutes of addition 3mLPBS buffer.
2. cell filtration
With 400 eye mesh screens the fibroblasts of adult human dermis that obtains filtered 1 time, 500~1000r/min Centrifugal 5min, discards buffer.
3. dyeing
Dye with 1ml PI dye liquor, be positioned in 4 DEG C of refrigerators, lucifuge 30 minutes.
4. flow cytomery
By the survival condition of the fibroblasts of adult human dermis that flow cytomery obtains, measure respectively The survival number of fibroblasts of adult human dermis, apoptosis number, calculate survival rate, and result sees table 3.
Table 3
Matched group A sample B sample C sample D sample
Skin Cell survival number (103) 0.4 0.4 1.2 1.9 0.6
Skin Cell apoptosis number (103) 2.7 2.6 1.8 1.2 2.6
Skin Cell survival rate (%) 12.90 13.33 40.00 61.29 18.75
Propionibacterium acnes can affect the growth of fibroblasts of adult human dermis, as can be seen from Table 3, adds After entering the wax prunus mume extract of the present invention, skin flbroblast, under the competition of propionibacterium acnes, is deposited Motility rate is significantly increased, and illustrates that this essence contributes to fibroblasts of adult human dermis to pathogenic microorganism Resistance.
Embodiment 4 verifies the effect of the scavenging activated oxygen of wax prunus mume extract
Under the effect of tryrosinase, levodopa (L-DOPA) is oxidized to tan DOPA color Element, under the existence condition of inhibitor, this reaction will be suppressed, the wax prunus mume (sieb.) sieb.et zucc. branch of the test present invention The extract suppression ratio to tyrosinase activity, comprises the steps:
A sample, C sample, D sample and the matched group that the embodiment of the present invention 2 second step is obtained The each sample of culture supernatant of sample respectively takes 0.1ml, is separately added in advance in 30 DEG C of waters bath with thermostatic control In the test tube of the L-DOPA substrate solution of the 2.8ml of insulation, mixing, it is subsequently adding the 600 of 0.1ml Carry out water-bath 10 minutes in 30 DEG C after the tyrosinase solution of unit/ml, fully mixing, use light splitting Photometer, measures the absorption peak of dopachrome at 475nm.
By the absorbance measured, calculate the dilution of stock suppression ratio (%) to tyrosinase activity, Seeing table 4, wherein, the computing formula of suppression ratio is as follows:
Suppression ratio=[1-(T1-T2)/(C1-C2)] × 100%
In above-mentioned computing formula,
C1 adds the mixture of tryrosinase and is surveyed by not adding sample (A sample, C sample, D sample) Absorbance;
C2 does not adds the mixture of tryrosinase for not adding sample (A sample, C sample, D sample) yet The absorbance surveyed;
T1 is surveyed by adding sample (A sample, C sample, D sample) and the mixture of tryrosinase Absorbance;
T2 does not adds the mixture institute of tryrosinase for adding sample (A sample, C sample, D sample) The absorbance surveyed.
Table 4
Sample C1 C2 T1 T2 Suppression ratio (%)
A sample 0.65 0.31 0.63 0.29 0.11
C sample 0.67 0.3 0.62 0.32 18.05
D sample 0.62 0.28 0.46 0.27 44.1
Matched group 0.68 0.33 0.61 0.26 0
As can be seen from Table 5, the wax prunus mume (sieb.) sieb.et zucc. branch extract obtained by the present invention is for the work of tryrosinase Property have obvious inhibitory action, along with concentration raise, inhibitory action strengthen, this can suppress mottle Formed, play the effect making skin-whitening.
The application verification of the wax prunus mume (sieb.) sieb.et zucc. branch compositions of embodiment 5 present invention
Cleaner arm, by the A sample described in the embodiment of the present invention 2 second step, C sample, D Sample is respectively coated the skin of 2.5cm × 2.5cm on arm, and is coated with normal saline for control sample In equal area, respectively 1 hour, 2 hours, observe skin condition after 5 hours and carry out record, The results are shown in Table 5.
Table 5
Test period A sample C sample D sample Matched group
1 hour Moistening Moistening Moistening, pale Moistening
2 hours Greasy Normally Moistening, pale The driest
5 hours Greasy Normally Normally Greasy
As can be seen from Table 5, after adding the wax prunus mume (sieb.) sieb.et zucc. branch extract of the present invention, the water holding capacity of skin Increasing, whitening skin and preserving moisture effect is obvious.
The wax prunus mume extract of the present invention can protect skin to reduce microorganism encroach, has minimizing ultraviolet Radiation, antioxidation etc. act on, thus protect Skin Cell, this wax prunus mume extract can also play to The effect of anti-scytitis, meanwhile can also reduce pigmentation, it is suppressed that mottle generates, and makes flesh Skin is pale vivid.

Claims (10)

1. a wax prunus mume extract, its each weight percentages of components is: nimbecetin 5~20%, Quercetin 10~30%, Cocositol 50~60%, and inevitably impurity.
2. the preparation method of wax prunus mume extract as claimed in claim 1, comprises the following steps:
1) by wax prunus mume (sieb.) sieb.et zucc. material clean, shred, sterilize;
2) by the wax prunus mume (sieb.) sieb.et zucc. material liquid nitrogen lyophilizing after sterilization, pulverizing, extractant is added, at airtight condition Under, ultrasonic extraction 0.5~2h, extraction temperature is 35~60 DEG C, supersonic frequency 60-100kHz; Wherein, the mass volume ratio of wax prunus mume (sieb.) sieb.et zucc. and extractant is 1:30~60;
3) it is centrifuged after extraction terminates, filters, collect filtrate, obtain the solution of wax prunus mume extract;
4) by step 3) solution of wax prunus mume extract that obtains, concentrate, utilize chromatographic column to chromatograph Purification, gradient elution, eluant is petroleum ether-acetone;
5) collect eluent, dry, obtain described wax prunus mume (sieb.) sieb.et zucc. branch extract.
3. the preparation method of wax prunus mume extract as claimed in claim 2, it is characterised in that step 2) in, Step 2) described in extractant selected from 70~90% aqueous solution of ethanol, ethyl acetate and saturated At least one in the aqueous solution of n-butyl alcohol.
4. the preparation method of wax prunus mume extract as claimed in claim 2 or claim 3, it is characterised in that step 2) In, the mass ratio of wax prunus mume (sieb.) sieb.et zucc. material and extractant is 1:35~45.
5. the preparation method of wax prunus mume extract as claimed in claim 3, it is characterised in that described step Rapid 2) carry out under anaerobic.
6. the preparation method of wax prunus mume extract as claimed in claim 2, it is characterised in that step 4) in, When utilizing column chromatography purification, with silica column purification 2~5 times, use hydroxypropyl polydextran gel Column chromatography purification 2~5 times, collect in eluant petroleum ether and acetone volume ratio at 100:6~12 Time eluent.
7. the preparation method of the wax prunus mume extract as described in any one of claim 3~6, it is characterised in that Described wax prunus mume (sieb.) sieb.et zucc. material is the branch of wax prunus mume (sieb.) sieb.et zucc. plant, stem, leaf or flower.
8. the compositions containing wax prunus mume extract described in claim 1, including: glycerol 2~7wt.%, Butanediol 3~5wt.%, 1,2-pentanediol 1~5wt.%, EDETATE SODIUM 0.1~0.4wt.%, sweet Oleostearin acid esters 1~3wt.%, hyaluronate sodium 0~0.1wt.%, xanthan gum 1~10wt.%, wax Prunus mume extract 2~8wt.%, surplus is water.
9. wax prunus mume extract application in cosmetics or health product as claimed in claim 1.
Apply the most as claimed in claim 9, it is characterised in that described cosmetics are whitening class, dispel Pox and/or antibacterial class cosmetics.
CN201610394829.3A 2016-06-06 2016-06-06 Chimonanthus praecox extract as well as preparation method and application thereof Pending CN105920059A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610394829.3A CN105920059A (en) 2016-06-06 2016-06-06 Chimonanthus praecox extract as well as preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610394829.3A CN105920059A (en) 2016-06-06 2016-06-06 Chimonanthus praecox extract as well as preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN105920059A true CN105920059A (en) 2016-09-07

Family

ID=56832365

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610394829.3A Pending CN105920059A (en) 2016-06-06 2016-06-06 Chimonanthus praecox extract as well as preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN105920059A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112920038A (en) * 2021-01-29 2021-06-08 嘉兴学院 Preparation method of norsesquiterpenoids in chimonanthus salicifolius

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103906524A (en) * 2011-04-06 2014-07-02 玫琳凯有限公司 Topical skin care formulations comprising plant extracts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103906524A (en) * 2011-04-06 2014-07-02 玫琳凯有限公司 Topical skin care formulations comprising plant extracts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
夏玮: "腊梅花中黄酮类化合物的UHPLC/QTOF-MS分析", 《中成药》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112920038A (en) * 2021-01-29 2021-06-08 嘉兴学院 Preparation method of norsesquiterpenoids in chimonanthus salicifolius

Similar Documents

Publication Publication Date Title
CN105769698A (en) Cosmetic composition without preservative and application of cosmetic composition
CN103565729B (en) Condensation and preparation method thereof is repaired in a kind of black Fructus Lycii moisturizing
CN105919110B (en) Black tea composite enzyme and preparation method thereof
KR20090129963A (en) Anti-aging or anti-oxidative composition comprising plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng
CN103190509A (en) Peony flower tea and preparation method thereof
CN110974740B (en) Plant two-step fermentation product with skin irritation and oxidation resisting effects and preparation method and application thereof
CN105647974A (en) Saccharomyces cerevisiae plant fermentation product and application thereof and skin external application preparations
CN104922171A (en) Use of extract of Chenopodium quinoa for preparing composition for promoting collagen production and resisting skin aging
CN110946813B (en) Compound fermentation extract containing cubilose and preparation method and application thereof
CN105722974A (en) Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method
CN111632012B (en) Compound probiotic fermented composition with whitening function and application thereof
CN108815072A (en) A kind of plant composition fermentation magma and its preparation method and application
CN103356425A (en) Peel-off ginseng mask and preparation method of mask
CN108042436B (en) Anti-aging and moisturizing blue copper peptide essence cream
KR20120009594A (en) Method for preparing detergent composition comprising morinda citriforia extract
JP2023171950A (en) Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic
CN105920059A (en) Chimonanthus praecox extract as well as preparation method and application thereof
KR101769755B1 (en) A leuconostoc mesenteroides gfc 160704, cosmetic composition including the leuconostoc mesenteroides gfc 160704 or its culture fluid, and manufacturing method of the cosmetic composition
CN102669520A (en) Nostoc flagelliforme polysaccharide oral liquid and preparation method thereof
KR101995557B1 (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
CN109730942A (en) One kind containing collagen hydrolysate, the skin care item and its preparation method and application of moisturizing moisturizing
CN108210438A (en) A kind of skin base solution based on American cockroach freeze-dried powder and preparation method thereof
KR102054100B1 (en) Cosmetic composition containing fermented extract of roots
CN114831918A (en) Traditional Chinese medicine composition fermentation liquor, preparation method and application thereof
CN105456132A (en) Composition of plant extracts and application of composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160907

WD01 Invention patent application deemed withdrawn after publication